Advertisement
Screener

Cue Biopharma, Inc. (CUE) Graph

CUE Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $7.88M; Research and development $49.01M; Operating expenses $95.57M; Income tax (m).
  • 2026-03-31: Revenue $5.69M; Research and development $6.90M; Operating expenses $11.04M; Income tax (m).
  • 2025-12-31: Revenue $21.94M*; Research and development $16.53M*; Operating expenses $19.96M*; Income tax (m).
  • 2025-09-30: Revenue $2.15M; Research and development $4.75M; Operating expenses $9.74M; Income tax (m).

Type Of Arrangement

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CUE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.BI Collaboration AndLicense Agreement$7.60MImmuno Scape CollaborationAnd License Agreement$300.00KRevenue$7.88MOperating expenses$95.57MOperating income-$87.70MResearch & development$49.01MNet income-$153.07M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$7.88M$49.01M$95.57M(m)-$153.07M
2026-03-31$5.69M$6.90M$11.04M(m)-$5.18M
2025-12-31$21.94M*$16.53M*$19.96M*(m)$1.58M*
2025-09-30$2.15M$4.75M$9.74M(m)-$7.45M
2025-06-30$2.95M$7.91M$11.59M(m)-$8.48M
2025-03-31$421.00K$8.55M$12.72M(m)-$12.26M
2024-09-30$3.34M$9.38M$12.15M(m)-$8.66M
2024-06-30$2.66M$9.53M$13.04M(m)-$10.17M
2024-03-31$1.72M$10.20M$14.38M(m)-$12.35M
2023-09-30$2.10M$9.87M$13.52M(m)-$11.01M
2023-06-30$1.38M$10.65M$14.90M(m)-$13.19M
2023-03-31$187.00K$9.39M$13.57M(m)-$13.11M
2022-09-30$68.00K$7.57M$11.10M(m)-$10.96M
2022-06-30$26.00K$9.59M$13.12M(m)-$13.21M
2022-03-31$1.00M$10.08M$15.24M(m)-$14.26M
2021-09-30$2.40M$11.29M$15.41M(m)-$12.99M
2021-06-30$2.74M$8.76M$13.04M(m)-$10.28M
2021-03-31$1.55M$9.82M$14.07M(m)-$12.51M
2020-09-30$704.00K$7.52M$10.84M(m)-$10.03M
2020-06-30$1.07M$8.12M$12.02M(m)-$10.83M
2020-03-31$900.00K$9.91M$13.89M(m)-$12.82M
2019-09-30$984.00K$5.30M$8.08M(m)-$6.99M
2019-06-30$1.05M$6.87M$10.29M$413.00K-$9.52M
2019-03-31$370.00K$8.35M$11.80M(m)-$11.27M
2018-09-30$449.00K$10.31M$13.21M(m)(m)
2018-06-30$172.00K$5.41M$7.64M(m)(m)
2018-03-31(m)$5.82M$7.52M(m)-$7.52M
2017-09-30(m)$4.00M$5.03M(m)-$5.03M
2017-06-30(m)$3.42M$4.41M(m)-$4.41M
2017-03-31(m)$2.46M$3.35M(m)-$3.35M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$13.56M$55.90M$106.61M(m)-$158.25M
2025-06-30$3.37M$16.46M$24.31M(m)-$20.74M
2024-06-30$4.38M$19.73M$27.43M(m)-$22.52M
2023-06-30$1.57M$20.04M$28.47M(m)-$26.29M
2022-06-30$1.03M$19.68M$28.36M(m)-$27.46M
2021-06-30$4.29M$18.58M$27.11M(m)-$22.78M
2020-06-30$1.98M$18.02M$25.91M(m)-$23.65M
2019-06-30$1.43M$15.22M$22.08M$413.00K-$20.79M
2018-06-30$363.00K$11.41M$15.34M(m)-$14.81M
2017-06-30(m)$5.88M$7.76M(m)-$7.76M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$5.52M$21.21M$34.05M(m)-$28.19M
2024-09-30$7.71M$29.11M$39.58M(m)-$31.18M
2023-09-30$3.67M$29.91M$41.99M(m)-$37.30M
2022-09-30$1.09M$27.25M$39.45M(m)-$38.42M
2021-09-30$6.69M$29.85M$42.51M(m)-$35.78M
2020-09-30$2.68M$25.54M$36.75M(m)-$33.68M
2019-09-30$2.41M$20.52M$30.16M$413.00K-$27.78M
2018-09-30$812.00K$21.72M$28.54M(m)-$27.36M
2017-09-30(m)$9.88M$12.79M(m)-$12.79M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$27.47M$37.74M$54.02M$500.00K-$26.60M
2024-12-31$9.29M$36.30M$50.79M$0.00-$40.67M
2023-12-31$5.49M$40.80M$57.64M(m)-$50.73M
2022-12-31$1.25M$38.58M$54.47M$0.00-$53.01M
2021-12-31$14.94M$41.35M$58.65M$495.00K-$44.16M
2020-12-31$3.15M$33.55M$48.20M$206.25K-$44.78M
2019-12-31$3.46M$27.49M$40.23M$412.50K-$36.70M
2018-12-31$1.14M$28.54M$39.84M$825.00K-$38.98M
2017-12-31(m)$18.90M$23.23M(m)-$23.23M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
MACROGENICS INC (MGNX)United States$0.242B-20.11
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55